Healthcare

An Appendix 3X is a standard ASX regulatory form that all listed entities are required to lodge whenever a new director is appointed to the board. The form requires disclosure of the incoming director's relevant interests in the company's securities at the date of …

Orphan Drug Designation is a special regulatory status granted by the FDA to drugs intended to treat rare diseases or conditions. It provides a range of incentives to encourage the development of therapies for conditions that affect relatively small patient populations and therefore face …

HeraMED's HeraCARE platform is a hybrid maternity care system designed to transform prenatal and postpartum care delivery through digital health technology. The platform enables remote monitoring of maternal health indicators, integrating medical-grade monitoring devices with a digital health application that supports both patients and …

The central operational theme for Nova Eye Medical Ltd is What Nova Eye Medical 2RT Retinal Therapy and iTrack Advance Achieve in Glaucoma. Operationally, management has directed executive focus and capital resources toward expanding surgeon adoption of the iTrack Advance canaloplasty system across the …

The central operational theme for Biome Australia Ltd is Why Biome Australia Clinically Validated Probiotic Medicines Drive PharmacyRevenueGrowth. Operationally, management has directed executive focus and capital resources toward expanding national pharmacy distribution of evidence-based probiotic formulations for sleep and cholesterol. According to formal market …

The central operational theme for OncoSil Medical Ltd is What OncoSil Medical Targeted Micro-Brachytherapy Delivers in Inoperable Pancreatic Tumors. Operationally, management has directed executive focus and capital resources toward monitoring commercial treatments and hospital reimbursement approvals across key European medical centers. According to formal …

The central operational theme for CSL Limited is Why CSL Limited Global Plasma Fractionation and Recombinant Yields Anchor Industry Leadership. Operationally, management has directed executive focus and capital resources toward optimizingManufacturingYieldimprovements and expanding global immunoglobulin commercial supply. According to formal market releases published on …